WallStreetZen

NYSE: NVS
Novartis Ag Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

NVS past earnings growth

How has NVS's earnings growth performed historically?
Company
24.38%
Industry
21.06%
Market
103.02%
NVS's earnings have grown slower (6.83% per year) than the US Drug Manufacturers - General industry average (16.78%)
Performance
NVS's earnings have grown slower (6.83% per year) than the US market average (30.18%)
Performance
NVS's earnings growth is accelerating - its growth over the last year (24.38%) is above its 5-year compound annual rate (6.83%)
Performance

NVS past revenue growth

How has NVS's revenue growth performed historically?
Company
4.09%
Industry
18.45%
Market
46.25%
NVS's revenue has grown slower (0.7% per year) than the US Drug Manufacturers - General industry average (5.44%)
Performance
NVS's revenue has grown slower (0.7% per year) than the US market average (19.19%)
Performance
NVS's revenue growth is accelerating - its growth over the last year (4.09%) is above its 5-year compound annual rate (0.7%)
Performance

NVS earnings and revenue history

Current Revenue
$51.6B
Current Earnings
$9.0B
Current Profit Margin
17.4%
NVS's has not demonstrated consistent long-term earnings growth over the past 10 years (-6.79%)
Performance

NVS Return on equity

Current Company
16.7%
Current Industry
33.2%
Current Market
32.8%
NVS's Return on Equity (16.7%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

NVS Return on assets

Current Company
7.1%
Current Industry
7.3%
Current Market
7.7%
NVS is generating lower Return on Assets (7.1%) than the US Drug Manufacturers - General industry average (7.54%)
Performance

NVS Return on capital employed

Current Company
12.44%
Current Industry
11.7%
NVS's ability to generate Return on Capital (12.44%) has decreased compared to 3 years ago (14.44%)
Performance

Novartis Ag Earnings & Revenue FAQ

What were NVS's earnings last quarter?

Novartis Ag (NYSE: NVS) reported Q2 2021 earnings per share (EPS) of $1.29, up 57.32% year over year. Total Novartis Ag earnings for the quarter were $2.90 billion. In the same quarter last year, Novartis Ag's earnings per share (EPS) was $0.82.

What was NVS's earnings growth in the past year?

As of Q3 2021, Novartis Ag's earnings has grown 24.38% year over year. This is 3.31 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 21.06%. Novartis Ag's earnings in the past year totalled $8.98 billion.

What was NVS's revenue last quarter?

Novartis Ag (NYSE: NVS) reported Q2 2021 revenue of $13.29 billion up 14.39% year over year. In the same quarter last year, Novartis Ag's revenue was $11.62 billion.

What was NVS's revenue growth in the past year?

As of Q3 2021, Novartis Ag's revenue has grown 4.09% year over year. This is 14.36 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 18.45%. Novartis Ag's revenue in the past year totalled $51.56 billion.
©2021 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.